<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0176226</article-id>
<article-id pub-id-type="publisher-id">PONE-D-16-45780</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cell adhesion</subject><subj-group><subject>Integrins</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular structures and organelles</subject><subj-group><subject>Extracellular matrix</subject><subj-group><subject>Integrins</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cell motility</subject><subj-group><subject>Cell migration</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Developmental biology</subject><subj-group><subject>Cell migration</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Connective tissue cells</subject><subj-group><subject>Fibroblasts</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Biological tissue</subject><subj-group><subject>Connective tissue</subject><subj-group><subject>Connective tissue cells</subject><subj-group><subject>Fibroblasts</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Biological tissue</subject><subj-group><subject>Connective tissue</subject><subj-group><subject>Connective tissue cells</subject><subj-group><subject>Fibroblasts</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cell motility</subject><subj-group><subject>Cell migration</subject><subj-group><subject>Cancer cell migration</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Developmental biology</subject><subj-group><subject>Cell migration</subject><subj-group><subject>Cancer cell migration</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Biological cultures</subject><subj-group><subject>Cell lines</subject><subj-group><subject>Cultured fibroblasts</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Microscopy</subject><subj-group><subject>Light microscopy</subject><subj-group><subject>Fluorescence microscopy</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Metastasis</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Basic cancer research</subject><subj-group><subject>Metastasis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular structures and organelles</subject><subj-group><subject>Cell membranes</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Inhibition of α<sub>v</sub>β<sub>3</sub> integrin induces loss of cell directionality of oral squamous carcinoma cells (OSCC)</article-title>
<alt-title alt-title-type="running-head">The α<sub>v</sub>β<sub>3</sub> integrin modulates cell directionality</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Montenegro</surname>
<given-names>Cyntia F.</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Casali</surname>
<given-names>Bruna C.</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Lino</surname>
<given-names>Rafael L. B.</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Pachane</surname>
<given-names>Bianca C.</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Santos</surname>
<given-names>Patty K.</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Horwitz</surname>
<given-names>Alan R.</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2372-7814</contrib-id>
<name name-style="western">
<surname>Selistre-de-Araujo</surname>
<given-names>Heloisa S.</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Lamers</surname>
<given-names>Marcelo L.</given-names>
</name>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Physiological Sciences, Center of Biological and Health Science, Federal University of São Carlos, Rod. Washington Luis, São Carlos, São Paulo, Brazil, CEP</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Cell Biology, University of Virginia, School of Medicine, Charlottesville, Virginia, United States of America</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Department of Morphological Sciences, Institute of Basic Health Sciences, Federal University of Rio Grande do Sul, Rua Sarmento Leite, Porto Alegre, RS, Brazil, CEP</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Languino</surname>
<given-names>Lucia R.</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Thomas Jefferson University, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con">
<p><list list-type="simple"> <list-item>
<p><bold>Conceptualization:</bold> HSSA MLL ARH.</p></list-item> <list-item>
<p><bold>Data curation:</bold> CFM RLBL.</p></list-item> <list-item>
<p><bold>Formal analysis:</bold> CFM RLBL BCP.</p></list-item> <list-item>
<p><bold>Funding acquisition:</bold> ARH HSSA.</p></list-item> <list-item>
<p><bold>Investigation:</bold> CFM BCC PKS RLBL BCP.</p></list-item> <list-item>
<p><bold>Methodology:</bold> CFM BCC.</p></list-item> <list-item>
<p><bold>Project administration:</bold> MLL.</p></list-item> <list-item>
<p><bold>Resources:</bold> MLL ARH HSSA.</p></list-item> <list-item>
<p><bold>Software:</bold> ARH.</p></list-item> <list-item>
<p><bold>Supervision:</bold> MLL HSSA.</p></list-item> <list-item>
<p><bold>Validation:</bold> MLL.</p></list-item> <list-item>
<p><bold>Visualization:</bold> CFM HSSA.</p></list-item> <list-item>
<p><bold>Writing – original draft:</bold> CFM HSSA.</p></list-item> <list-item>
<p><bold>Writing – review &amp; editing:</bold> CFM HSSA MLL ARH.</p></list-item></list>
</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">hsaraujo@ufscar.br</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>12</volume>
<issue>4</issue>
<elocation-id>e0176226</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>11</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>8</day>
<month>4</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-year>2017</copyright-year>
<copyright-holder>Montenegro et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0176226"/>
<abstract>
<p>The connective tissue formed by extracellular matrix (ECM) rich in fibronectin and collagen consists a barrier that cancer cells have to overpass to reach blood vessels and then a metastatic site. Cell adhesion to fibronectin is mediated by α<sub>v</sub>β<sub>3</sub> and α<sub>5</sub>β<sub>1</sub> integrins through an RGD motif present in this ECM protein, thus making these receptors key targets for cell migration studies. Here we investigated the effect of an RGD disintegrin, Dis<italic>Ba</italic>-01, on the migration of human fibroblasts (BJ) and oral squamous cancer cells (OSCC, SCC25) on a fibronectin-rich environment. Time-lapse images were acquired on fibronectin-coated glass-bottomed dishes. Migration speed and directionality analysis indicated that OSCC cells, but not fibroblasts, showed significant decrease in both parameters in the presence of Dis<italic>Ba</italic>-01 (1μM and 2μM). Integrin expression levels of the α<sub>5</sub>, α<sub>v</sub> and β<sub>3</sub> subunits were similar in both cell lines, while β1 subunit is present in lower levels on the cancer cells. Next, we examined whether the effects of Dis<italic>Ba</italic>-01 were related to changes in adhesion properties by using paxillin immunostaining and total internal reflection fluorescence TIRF microscopy. OSCCs in the presence of Dis<italic>Ba</italic>-01 showed increased adhesion sizes and number of maturing adhesion. The same parameters were analyzed usingβ3-GFP overexpressing cells and showed that β3 overexpression restored cell migration velocity and the number of maturing adhesion that were altered by Dis<italic>Ba</italic>-01. Surface plasmon resonance analysis showed that Dis<italic>Ba</italic>-01 has 100x higher affinity for α<sub>v</sub>β<sub>3</sub> integrin than forα5β1 integrin. In conclusion, our results suggest that the α<sub>v</sub>β<sub>3</sub> integrin is the main receptor involved in cell directionality and its blockage may be an interesting alternative against metastasis.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution>FAPESP</institution>
</funding-source>
<award-id>2013/00798-2</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Selistre de Araujo</surname>
<given-names>Heloisa Sobreiro</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution>CNPq</institution>
</funding-source>
<award-id>308096/2013-4</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Selistre de Araujo</surname>
<given-names>Heloisa Sobreiro</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award003">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id>
<institution>National Institutes of Health</institution>
</institution-wrap>
</funding-source>
<award-id>GM23244</award-id>
<principal-award-recipient>Alan Rick Horwitz</principal-award-recipient>
</award-group>
<award-group id="award004">
<funding-source>
<institution>CNPq</institution>
</funding-source>
<award-id>140130/2012-8</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Montenegro</surname>
<given-names>Cyntia F.</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This work was supported by National Institute of Health [NIH, GM23244], Alan R. Horwitz, <ext-link ext-link-type="uri" xlink:href="https://www.nih.gov" xlink:type="simple">https://www.nih.gov</ext-link>; FAPESP 2013/00798-2, HSS Araujo, <ext-link ext-link-type="uri" xlink:href="http://www.fapesp.br" xlink:type="simple">www.fapesp.br</ext-link>; CNPq 140130/2012-8, CF Montenegro, 308096/2013-4 HSS Araujo, <ext-link ext-link-type="uri" xlink:href="http://www.cnpq.br" xlink:type="simple">www.cnpq.br</ext-link>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="5"/>
<table-count count="0"/>
<page-count count="14"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Oral squamous cell carcinoma (OSCC) is responsible for 90% of all oral cancers occurring at different sites of the oral mucosa [<xref ref-type="bibr" rid="pone.0176226.ref001">1</xref>, <xref ref-type="bibr" rid="pone.0176226.ref002">2</xref>]. The exposure to chemical, physical or biological agents with mutagenic and carcinogenic properties leads mutated keratinocytes to proliferate and invade the connective tissue. OSCCs responsiveness to chemotherapy is low likely due to the heterogeneity of tumor cell population; the high local recurrence rate of this disease results in a 5 year survival rate of only 40–50% [<xref ref-type="bibr" rid="pone.0176226.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0176226.ref003">3</xref>].</p>
<p>Tumor cell migration is pivotal step in invasion and metastases. The change from a non-migratory to a migratory phenotype results in detachment from the primary tumor, invasion into the surrounding tissues, and entry into blood and lymph vessels [<xref ref-type="bibr" rid="pone.0176226.ref004">4</xref>, <xref ref-type="bibr" rid="pone.0176226.ref005">5</xref>]. Throughout this process, epithelial-derived tumor cells need to adapt to the changing environment, reflecting the change from a laminin-enriched basal membrane to a connective tissue rich in fibronectin and collagen. Previous studies showed that more aggressive OSCCs correlate with increased presence of fibronectin throughout the tissue, particularly at the invasion front [<xref ref-type="bibr" rid="pone.0176226.ref006">6</xref>, <xref ref-type="bibr" rid="pone.0176226.ref007">7</xref>], which might result in a fast single-cell migration mode [<xref ref-type="bibr" rid="pone.0176226.ref008">8</xref>].</p>
<p>Cell migration is a complex and cyclic process mediated by adhesion molecules such as the integrin receptors [<xref ref-type="bibr" rid="pone.0176226.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0176226.ref011">11</xref>]. They are composed of two different subunits, α and β which may assemble into 24 differently combined heterodimers with individual specificities to ECM proteins. Although some integrins share affinity to the same ligands, they may trigger different signaling pathways [<xref ref-type="bibr" rid="pone.0176226.ref012">12</xref>–<xref ref-type="bibr" rid="pone.0176226.ref014">14</xref>] such as the integrins α<sub>5</sub>β<sub>1</sub> and α<sub>v</sub>β<sub>3</sub> that bind to fibronectin through a RGD (arginine-glycine-aspartic acid) motif but differentially regulates adhesion maturation [<xref ref-type="bibr" rid="pone.0176226.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0176226.ref016">16</xref>]. Therefore, the use of peptides that bind to integrins could be considered a strategy to impair cell motility and decrease the possibility of metastasis.</p>
<p>Therefore, the blockage of integrin activity affects several adhesion dependent processes as migration, proliferation, apoptosis, among other processes [<xref ref-type="bibr" rid="pone.0176226.ref017">17</xref>–<xref ref-type="bibr" rid="pone.0176226.ref021">21</xref>]. For instance, disintegrins, a family of low molecular weight, cysteine-rich peptides discovered in snake venoms were found to cause platelet aggregation inhibition, by binding to the integrin α<sub>IIb</sub>β<sub>3</sub> [<xref ref-type="bibr" rid="pone.0176226.ref022">22</xref>, <xref ref-type="bibr" rid="pone.0176226.ref023">23</xref>]. Dis<italic>Ba</italic>-01 (disintegrin of <italic>Bothrops alternatus</italic>) is a recombinant RGD containing disintegrin that inhibits cell migration [<xref ref-type="bibr" rid="pone.0176226.ref024">24</xref>], <italic>in vivo</italic> angiogenesis [<xref ref-type="bibr" rid="pone.0176226.ref025">25</xref>], pulmonary metastasis [<xref ref-type="bibr" rid="pone.0176226.ref026">26</xref>] and is able to decrease the expression of VEGF receptors in endothelial cells [<xref ref-type="bibr" rid="pone.0176226.ref027">27</xref>]. Since ECM components are able to modify the adhesion properties of tumor cells and elicit a migratory behavior [<xref ref-type="bibr" rid="pone.0176226.ref028">28</xref>], we hypothesized that the selective blockage of integrin receptors by an RGD disintegrin might impair the migratory process of OSCC cells on a fibronectin enriched environment.</p>
<p>In this study, we show that Dis<italic>Ba</italic>-01 decreased migration speed, directionality and changed the migration mode of a highly invasive OSCC cell line from single to collective cell migration but had no effect on fibroblasts. This selective effect on epithelial-derived tumor cells was accompanied by a modulation of adhesion dynamics and was rescued by the overexpression of β3 integrin. Together, these data strongly suggest thatαvβ3 integrin is the major receptor involved in cell speed and directionality of OSCCs and it can be a critical target for therapy against metastasis.</p>
</sec>
<sec id="sec002" sec-type="materials|methods">
<title>Material and methods</title>
<sec id="sec003">
<title>Dis<italic>Ba</italic>-01 expression and purification</title>
<p>Dis<italic>Ba</italic>-01 is a recombinant disintegrin produced from a cDNA venom gland library of <italic>B</italic>. <italic>alternatus</italic>, since the native disintegrin could not be purified from the venom due to low yields in protein preparations [<xref ref-type="bibr" rid="pone.0176226.ref026">26</xref>]. The coding region corresponds to an RGD containing motif disintegrin of 78 amino acids residues (GenBank accession AY259516). Expression and purification of the recombinant His-tag protein were performed as previously described [<xref ref-type="bibr" rid="pone.0176226.ref026">26</xref>]. Molecular modeling and adhesion assays suggested that the fusion His-tag peptide was not involved on integrin binding and therefore its proteolytic removal would not be needed [<xref ref-type="bibr" rid="pone.0176226.ref026">26</xref>–<xref ref-type="bibr" rid="pone.0176226.ref027">27</xref>].</p>
</sec>
<sec id="sec004">
<title>Cell culture and transfection</title>
<p>SCC25 cells (ATCC1 CRL-1628™) were grown in DMEM/F12 with 15mM HEPES and 0.5mM sodium pyruvate (Gibco), FBS 10% and hydrocortisone (400ng/ml, Sigma), while BJ cells (ATCC® CRL2522™) in DMEM Glutamax with 1% non-essential amino acids (NEAA) and 10% fetal bovine serum. Cal27 (ATCC1 CRL-2095™) were cultivated in DMEM high glucose (Gibco) supplemented with 10% Fetal Bovine Serum (FBS). All cells were maintained in incubator at 37°C and 5% CO<sub>2</sub>. SCC25 cell was considered a highly aggressive oral squamous cell carcinoma (OSCC) cell line due to its low E-cadherin content when compared to Cal27, an OSCC cell line considered to be minimally invasive [<xref ref-type="bibr" rid="pone.0176226.ref028">28</xref>]. For Total Internal Reflectance Fluorescence (TIRF) microscopy, SCC25 were transfected using TransIT-2020 (Mirus) 24hs before the experiment with 0.5μg of paxillin-GFP plasmid [<xref ref-type="bibr" rid="pone.0176226.ref029">29</xref>]. For β3 subunit overexpression studies, cells were transfected with 0.5μg β3-GFP and 0.5μg paxillin-mko.</p>
<sec id="sec005">
<title>Migration and adhesions dynamics assays</title>
<p>Both assays used 3cm glass-bottomed dishes containing fibronectin (2μg/mL) and/or Dis<italic>Ba</italic>-01 (1 and 2μM) as a substrate or diluted in the media. Cells were plated with serum free media (CCM1, Thermo Fisher Scientific) and left in the incubator at 37°C for 1 hour (phase microscopy) or 20 min (TIRF microscopy) before imaging. At least 3 different experiments were performed for each group.</p>
<p>For time-lapse phase microscopy, images were acquired from either: BJ (human fibroblasts) and SCC25 (OSCC) over 8 hours with a 10 minute interval, at 37°C using a Nikon TE300 microscope (10x 0.25 NA CFI Achro DL106 Nikon objective), with a charge coupled device camera (Orca II, Hamamatsu Photonics, Iwata-City, Japan) using Metamorph software (Molecular Devices), as previously described [<xref ref-type="bibr" rid="pone.0176226.ref030">30</xref>]. Image J software in manual tracking was used to analyze migration parameters. Migration speed was determined by the ratio between the total distance and duration of cell migration; while directionality was determined by X and Y coordinates normalized to a “zero” starting point.</p>
<p>For time-lapse movies on TIRF microscopy, only the SCC25 cell was used. Images were captured every 3 seconds over 20 minutes using an Olympus IX70 inverted microscope (63x 1.45 NA oil Olympus PlanAplo 660 TIRFM objective), fitted with a Ludl modular automation controller (Ludl Electronic Products), a charge-couple device camera (RetigaExi, Qimaging), and Metamorph software. GFP was excited using the 488nm laser line of an Argon laser (Melles Griot), a dichroic mirror (HQ485/30) and an emission filter (HQ525/50). To estimate the rate of adhesion maturation, nascent adhesions were identified as the adhesions formed at the border of the cell membrane during protrusion and mature adhesions were identified as those that persisted through membrane protrusion, growing in size and elongating.</p>
<p>Additionally, invasion assays were made using 24-well plate Matrigel™ invasion chambers (Corning). DMEM/F12 medium with 5% FBS was pipetted into the wells, except on the negative control where serum-free F12 medium was used. SCC-25 cells (1 x 10<sup>5</sup> cells) were treated with 1000 nM or 2000 nM Dis<italic>Ba</italic>-01 on serum-free F12 medium for 30 minutes. After that, the membrane-containing chamber was added to the well and treated or not-treated cells were applied. The invasion occurred for 48 hours at 37°C. The chamber membrane was fixed in 4% paraformaldehyde and cell nucleus was stained using DAPI. Membranes were assembled in slides using Vectashield<sup>®</sup> mounting media (Vector Laboratories) and cell count was performed on automated fluorescence microscope system, ImageXpress Micro (Molecular Devices).</p>
</sec>
<sec id="sec006">
<title>Western blots</title>
<p>Cells were trypsinized, washed and lysed in RIPA Buffer (25mMTris-HCL pH 7.6, 150mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) with protease (P8340, Sigma Aldrich) and phosphate cocktails (P8340, Sigma Aldrich). The lysates were separated by 4–20% precast polyacrylamide gel (BioRad) and proteins transferred to PVDF membranes (BioRad), blocked for 1 hour with 5% defatted milk in a PBS/0.5% Tween 20 at room temperature. Samples were immunoassayed for α<sub>v</sub>, β<sub>3</sub>, α<sub>5</sub>, β<sub>1</sub>, E-cadherin, N-cadherin and α-Tubulin (Cell Signaling, USA) using Pierce ECL Western Blotting Substrate (Thermo Scientific).</p>
</sec>
<sec id="sec007">
<title>Immunofluorescence</title>
<p>Cells were incubated with Dis<italic>Ba</italic>-01 for 3 hours on fibronectin (2μg/ml) covered glass coverslips on CCM1 media. Then, cells were washed with PBS, fixed with formaldehyde 4%, and permeabilized using TritonX-100 (0.3%). Nonspecific binding sites were blocked with normal goat serum, and the cells incubated overnight with anti-paxilin antibody (BD Bioscience). After washing, cells were incubated with secondary antibodies against mouse bound to Alexa488 dye (Molecular Probes, Oregon, USA) and the actin filaments were marked with phalloidin conjugated to rhodamine (Molecular Probes, Oregon, USA). Images were obtained on a confocal microscope (Olympus FluoView 1000, Tokyo, Japan) with the 63x objective (UPlanSApo x63, 1.20 NA, oil immersion objective). Alexa488 was excited via the 488nm line of an Ar laser (Melles Griot, Albuquerque, NM), and rhodamine via the 543nm line of a Helium-Neon laser (Melles Griot, Albuquerque, NM). Images were acquired using FluoView software (Olympus, Tokyo, Japan). The Z-stacks were acquired from cells using 3 0.1μm step size slices (0.3μm of the cell) that were merged using the ImageJ software tool “Z-stack/sum”.</p>
</sec>
<sec id="sec008">
<title>Surface plasmon resonance (SPR)</title>
<p>The affinity of Dis<italic>Ba</italic>-01 to immobilized integrins was measured using SPR (BIAcore T200; GE Healthcare, Little Chalfont, UK). α<sub>5</sub>β<sub>1</sub> and α<sub>V</sub>β<sub>3</sub> integrins (R&amp;D, Minneapolis, MN, USA) were covalently attached via amine coupling (pH Scouting) to sensor chip CM5(GE Healthcare, Little Chalfont, UK). The bound ligand was then perfused in buffer containing 0.01 M Hepes, pH 7.4, 0.15 M NaCl, and 0.005 (v/v) Surfactant P20 (HBS–EP) at 25°C and flow rate of 30 μL/min. Association and dissociation constant rates were calculated by curve fitting, using BIA evaluation 1.1 software, assuming that Dis<italic>Ba</italic>-01 is monomeric with a MR of 12,000 Da. After testing the sensor chip in a pH gradient (pH Scouting), integrins α<sub>5</sub>β<sub>1</sub> (pH 4.5) and α<sub>V</sub>β<sub>3</sub> (pH 4.0) were immobilized onto the sensor chip to get a 4,325.2 RU (Resonance Unit) and a 6,677.1 RU, respectively. Chip regeneration was done by injection of Gly HCl 2M, pH 2.0 for 10s. Dis<italic>Ba</italic>-01 (0.1–100 μM) was injected at increasing concentrations onto the sensor chip with both immobilized integrins and the association constant between Dis<italic>Ba</italic>–01 and the integrins was calculated via GraFit 5.0 software.</p>
</sec>
</sec>
<sec id="sec009">
<title>Statistical analysis</title>
<p>One way analysis of variance (ANOVA) was used followed by Tukey´s post test and student t-test for the TIRF microscopy assays.</p>
</sec>
</sec>
<sec id="sec010" sec-type="results">
<title>Results</title>
<sec id="sec011">
<title>Dis<italic>Ba</italic>-01 selectively affects OSCC migration</title>
<p>As shown in our previous work, Dis<italic>Ba</italic>-01 inhibits cancer cell and fibroblast migration using a transwell migration assay [<xref ref-type="bibr" rid="pone.0176226.ref024">24</xref>]. Therefore, to investigate its potential effect on cell migration in a fibronectin rich environment we used two human cell lines that exhibit single cell migration: fibroblasts (BJ) and a highly invasive/low differentiated oral squamous carcinoma cell line (SCC25).Time-lapse movies (8h) were performed on both cell lines plated on glass-bottomed dishes coated with fibronectin (2μg/ml) in the presence/absence of Dis<italic>Ba</italic>-01 (1 or 2μM) in the media or in the substrate. Individual migratory cells were tracked and analyzed for migration speed and directionality (total net translocation from the origin point). The fibroblasts (n = 3 experiments) were not detectably affected by Dis<italic>Ba</italic>-01, even at a high concentrations (2μM) when compared with control cells (<xref ref-type="fig" rid="pone.0176226.g001">Fig 1A</xref>, <xref ref-type="supplementary-material" rid="pone.0176226.s002">S1 Movie</xref>). However, the OSCC migration speed decreased by ~40% (n = 3 experiments, p&lt;0.0001) when plated in the presence of similar amounts of Dis<italic>Ba</italic>-01. This effect was more pronounced for migration directionality (<xref ref-type="fig" rid="pone.0176226.g001">Fig 1B</xref>, <xref ref-type="supplementary-material" rid="pone.0176226.s003">S2 Movie</xref>). While OSCC plated only in fibronectin exhibited a fast, individual and directionally persistent migration behavior, cells treated with 1μM of Dis<italic>Ba</italic>-01 in the media or in the substrate lost their directionality and moved in circles with a tendency to migrate in pairs (collectively). This selective effect of Dis<italic>Ba</italic>-01 in the tumor cells migration may reflect a differential effect on cell-ECM adhesive properties.</p>
<fig id="pone.0176226.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0176226.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Dis<italic>Ba</italic>-01 inhibits the migration of OSCC cell line.</title>
<p>(A) Dis<italic>Ba</italic>-01 significantly inhibited the migration speed of Oral Squamous Cell Carcinoma cells (SCC25) cells but not in fibroblasts (BJ) on both conditions tested (Media = DisBa-01 in the media; Subs = DisBa-01 in the substrate). Results were calculated as % of control. Statistical analysis was performed using ANOVA (one-way) followed by Tukey’s post-test, p&lt;0.0001. (B) Migration tracks of SCC25 cells treated with Dis<italic>Ba</italic>-01 in the concentrations of 2μM indicates a loss of directionality when compared to the control tracks. Each individual line represents a cell path translated to a common origin.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0176226.g001" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec012">
<title>Dis<italic>Ba</italic>-01 modulates cells adhesive properties of OSCC</title>
<p>We studied whether Dis<italic>Ba</italic>-01effects arose from altered adhesion by immunostaining OSCCs and fibroblasts for paxillin, a marker for nascent adhesions [<xref ref-type="bibr" rid="pone.0176226.ref031">31</xref>].Fibroblasts have small adhesions at the cell border, which are present in rapidly migrating but not stationary cells. Dis<italic>Ba</italic>-01 showed no alterations on paxillin distribution for these cells (<xref ref-type="fig" rid="pone.0176226.g002">Fig 2A</xref>). In contrast, significant changes were observed in the adhesions in OSCCs, including an increase in the size and number of adhesions in the presence of Dis<italic>Ba</italic>-01 in the media or in the substrate when compared to cells plated only on fibronectin (<xref ref-type="fig" rid="pone.0176226.g002">Fig 2B</xref>).</p>
<fig id="pone.0176226.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0176226.g002</object-id>
<label>Fig 2</label>
<caption>
<title>OSCCs treated with Dis<italic>Ba</italic>-01 show an increase in adhesions area and turnover.</title>
<p>Cells were allowed to spread for 3 hours on fibronectin (2μg/ml) coated dishes, subsequently fixed, stained for paxillin and analyzed by confocal microscopy. <bold>(</bold>A) Fibroblasts show a large number of small adhesions (red arrow) with no differences between cells with or without Dis<italic>Ba</italic>-01 treatment, while SSC25 treated cells show larger (red arrow) adhesions and rounded shape morphology in the presence of Dis<italic>Ba</italic>-01 (2μM). Actin staining and negative control are shown on the right. (B) Percentage of maturing adhesions on TIRF time-lapse movies in the absence or presence of Dis<italic>Ba</italic>-01, (C) in the adhesion area (D) and in the protrusions area (p&lt;0.05). Data was obtained from 3 independent experiments resulting in the analysis of 13–15 protrusions and 64–84 adhesions per experimental condition.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0176226.g002" xlink:type="simple"/>
</fig>
<p>To further investigate the adhesion dynamics seen at the paxillin immunostaining, SCC25 cells were transfected with paxillin-GFP and plated on fibronectin coated dishes (2μg/mL) 24h later in the presence/absence of Dis<italic>Ba</italic>-01 in the media or in the substrate. Then, maturation rate was imaged on TIRF microscopy every 3 seconds during 20 minutes. Dis<italic>Ba</italic>-01 increased the rate of adhesion maturation and the average area of each adhesion in OSCCs (<xref ref-type="fig" rid="pone.0176226.g002">Fig 2</xref>, <xref ref-type="supplementary-material" rid="pone.0176226.s004">S3 Movie</xref>). During the migration process, cells extend their membrane to form the lamellipodia and then attach the membrane to the extracellular matrix. The area of these protruding membranes was also measured and it was ~3x larger in Dis<italic>Ba</italic>-01 treated OSCC than control cells (n = 3 cells, p&gt;0.0005). Taken together, these data show that Dis<italic>Ba</italic>-01exhibits a differential cell type dependent effect on cell adhesion properties.</p>
<p>Fibronectin is a glycoprotein found on the ECM that interacts mainly with integrins α<sub>v</sub>β<sub>3</sub> and α<sub>5</sub>β<sub>1</sub> through the RGD motifs in its structure [<xref ref-type="bibr" rid="pone.0176226.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0176226.ref032">32</xref>]. A possible mechanism for the differential effects of Dis<italic>Ba</italic>-01 on adhesion properties is that the cell lines show different levels of integrin receptors for fibronectin. To test this hypothesis, we analyzed the integrin expression level on fibroblasts (BJ), a highly invasive/low differentiated (SCC25) and a low invasive/highly differentiated (Cal27) OSCC cell line (<xref ref-type="fig" rid="pone.0176226.g003">Fig 3</xref>). We observed that the low invasive/high differentiated OSCC cell line (Cal27) presents only low levels of αv subunit, which might explain the poor migratory performance observed on fibronectin [<xref ref-type="bibr" rid="pone.0176226.ref008">8</xref>]. However, fibroblasts showed high levels of all fibronectin-related integrin subunits, which corroborates to the fast single cell migration phenotype. When we analyzed the integrin levels of the highly invasive OSCC cell line, besides the high level of alpha-subunits, these cells show low levels of β1 and high levels of β3 subunits, which indicates that the migration process of this epithelial-derived tumor cell line on fibronectin relies mostly on β3 activity. Since Dis<italic>Ba</italic>-01 is an RGD disintegrin, this result suggests that Dis<italic>Ba</italic>-01 could be selectively acting on α<sub>v</sub>β<sub>3</sub> integrin of OSCC cells. Since highly invasive OSCC cells migrate in a collective way in matrigel but individually in fibronectin [<xref ref-type="bibr" rid="pone.0176226.ref008">8</xref>], we also tested if Dis<italic>Ba</italic>-01 could inhibit matrigel invasion. In fact, Dis<italic>Ba</italic>-01 (1 and 2 μM) inhibited OSCC invasion (approx. 40 and 50%, respectively) through matrigel (<xref ref-type="supplementary-material" rid="pone.0176226.s001">S1 Fig</xref>), thus indicating that this disintegrin can inhibit both forms of migration.</p>
<fig id="pone.0176226.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0176226.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Fibronectin-related integrin receptors show differential expression according to the differentiation level of the tumor cell.</title>
<p>Cells lysates of fibroblasts (BJ), highly invasive OSCC (SCC25) or poor invasive OSCC (Cal27 were submitted to western blot for analysis of fibronectin-related integrins. BJ and SCC25 contain α<sub>v</sub>, β<sub>3</sub> and α<sub>5</sub> integrin subunits in similar amounts while β<sub>1</sub> is present in smaller amounts on SCC25 cells. E-cadherin and N-cadherin are differentiation markers.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0176226.g003" xlink:type="simple"/>
</fig>
<p>To further analyze this result and confirm that the effects of Dis<italic>Ba</italic>-01 on migration and adhesion of OSCC cells were caused by the interaction of the disintegrin with the α<sub>v</sub>β<sub>3</sub> and not α<sub>5</sub>β<sub>1</sub>integrin, the main receptors involved in fibronectin binding [<xref ref-type="bibr" rid="pone.0176226.ref015">15</xref>], the binding between the disintegrin and purified integrins (α<sub>v</sub>β<sub>3</sub>, α<sub>5</sub>β<sub>1</sub>) were analyzed by SPR. The interaction between Dis<italic>Ba</italic>-01 and the α<sub>v</sub>β<sub>3</sub> integrin was about 100x higher than that for α<sub>5</sub>β<sub>1</sub>integrin (<italic>K</italic><sub>d</sub> 7.62 x10<sup>–5</sup>M) indicating a stronger affinity of the disintegrin for the α<sub>v</sub>β<sub>3</sub>integrin. This difference can also be seen in <xref ref-type="fig" rid="pone.0176226.g004">Fig 4</xref>.</p>
<fig id="pone.0176226.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0176226.g004</object-id>
<label>Fig 4</label>
<caption>
<title>DisBa-01 interacts specifically with integrin α<sub>V</sub>β<sub>3.</sub></title>
<p>(A) Response of increasing concentrations of Dis<italic>Ba</italic>-01 interacting with the α<sub>V</sub>β<sub>3</sub> integrin immobilized to the sensor chip. Starting at the time “0” and increasing its affinity as DisBa-01 concentration increases. (B) Response of increasing concentrations of Dis<italic>Ba</italic>-01 interacting with the α<sub>5</sub>β<sub>1</sub>. As the concentration of Dis<italic>Ba</italic>-01 increases, the affinity curves show very little displacement. (Single column- print in color)</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0176226.g004" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec013">
<title>β3 overexpression recovered Dis<italic>Ba</italic>-01 effects</title>
<p>Dis<italic>Ba</italic>-01 interacts with α<sub>v</sub>β<sub>3</sub> integrins [<xref ref-type="bibr" rid="pone.0176226.ref026">26</xref>], suggesting that the interaction between Dis<italic>Ba</italic>-01 and integrins impairs the migratory activity of OSCC cells. To test this hypothesis, OSCCs were transfected with β<sub>3</sub> subunit, plated on fibronectin-covered dishes in the presence/absence of Dis<italic>Ba</italic>-01, and migration properties were assessed. Expression levels of two plasmid concentrations for β3 subunit had shown that the lower concentration had little effect whereas the higher concentration, the chosen one, was closer to the BJ integrin levels (<xref ref-type="fig" rid="pone.0176226.g005">Fig 5A</xref>, <xref ref-type="supplementary-material" rid="pone.0176226.s005">S4 Movie</xref>). It was observed that the overexpression of β<sub>3</sub> subunit restored the migration speed and directionality of cells plated in the presence of Dis<italic>Ba</italic>-01. Adhesion and protrusion areas of cells overexpressing β<sub>3</sub> integrin with or without Dis<italic>Ba</italic>-01 were assessed both by immunostaining for paxillin and co-transfection with paxillin-mkousing confocal and TIRF microscopy, respectively. Overexpression of β<sub>3</sub> integrin rescued cells from a phenotype of larger adhesions and protrusions and slower migration (<xref ref-type="fig" rid="pone.0176226.g005">Fig 5</xref> and <xref ref-type="supplementary-material" rid="pone.0176226.s006">S5 Movie</xref>) such as the phenotype induced byDis<italic>Ba</italic>-01 (2μM), which corroborates with the hypothesis that the inhibition of β<sub>3</sub> integrin by Dis<italic>Ba</italic>-01is the probable mechanism by which Dis<italic>Ba</italic>-01 impairs the migration properties of OSCC cells.</p>
<fig id="pone.0176226.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0176226.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Overexpression of β3 subunit recovered DisBa-01 effects on migration speed and adhesion dynamics of OSCC cells.</title>
<p>(A) SCC25 cells were transfected with GFP-β<sub>3</sub> 0.5 and 1μg of plasmid. Protein bands show the levels of GFP-β<sub>3</sub> and endogenous β<sub>3</sub> expressed by SCC25 cells. (B) Migrations speed analysis shows no differences between control and Dis<italic>Ba</italic>-01 treated cells. (C) Representative images of β<sub>3</sub> overexpressing cells (indicated with arrows) stained for paxillin. (D) β<sub>3</sub> overexpressing cells with Dis<italic>Ba</italic>-01 reduced the number of adhesions maturation, similar to the controls, when compared with the previous TIRF experiment. (E) DisBa-01 effect over the area of adhesions and (F) area of protrusion was also was reverted on β<sub>3</sub> overexpressing cells treated with Dis<italic>Ba</italic>-01.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0176226.g005" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec014" sec-type="conclusions">
<title>Discussion</title>
<p>Tumor metastasis is a major cause of clinical failure in cancer treatment and might be influenced by extrinsic factors, such as the composition of the environment, as well as by intrinsic migratory properties of tumor cells. Also, tumor cell plasticity is a response to micro environmental changes and often influences tumor progression, invasion and resistance to therapy [<xref ref-type="bibr" rid="pone.0176226.ref033">33</xref>, <xref ref-type="bibr" rid="pone.0176226.ref034">34</xref>]. Alterations in matrix density, pliability, and composition, the nature of the adhesion receptors such as integrins or cadherins, respectively, and expression of cytoskeletal adaptor proteins can lead to interconvertible changes on migration mode depending on each cell intrinsic capacities [<xref ref-type="bibr" rid="pone.0176226.ref008">8</xref>, <xref ref-type="bibr" rid="pone.0176226.ref034">34</xref>]. Therefore, the blockage of the interaction of tumor cells with the extracellular matrix is an interesting alternative for complementary therapies. For instance, cilengitide is a RGD cyclic pentapeptide that selectively inhibits of αvβ5 and α<sub>v</sub>β<sub>3</sub> integrins and results from phase 2 trials show an antitumor activity against glioblastoma although it failed to improve patient outcome in phase 3 trials [<xref ref-type="bibr" rid="pone.0176226.ref035">35</xref>–<xref ref-type="bibr" rid="pone.0176226.ref036">36</xref>]. Despite this fact, targeting integrins remains an interesting strategy to disrupt cell-matrix interactions in cancer therapy, according to the authors.</p>
<p>We demonstrated that Dis<italic>Ba</italic>-01, an RGD disintegrin, present on media or substrate, was able to significantly decrease cell migration and cell directionality of highly invasive OSCC, on fibronectin coated dishes but it did not affect fibroblasts. Since soluble and immobilized disintegrin forms triggered opposite results in the past [<xref ref-type="bibr" rid="pone.0176226.ref037">37</xref>], both forms were tested. Migration initiates with biochemical or mechanical cues from the extracellular environment [<xref ref-type="bibr" rid="pone.0176226.ref011">11</xref>, <xref ref-type="bibr" rid="pone.0176226.ref038">38</xref>]. As demonstrated by previous studies, fibronectin induces migration of different cells lines including low and highly differentiated OSCC cells [<xref ref-type="bibr" rid="pone.0176226.ref008">8</xref>, <xref ref-type="bibr" rid="pone.0176226.ref039">39</xref>–<xref ref-type="bibr" rid="pone.0176226.ref040">40</xref>]. One interesting finding was that OSCC cells in the presence of Dis<italic>Ba</italic>-01 migrated in a similar fashion of low invasive OSCC cells, Cal27, also plated over fibronectin. Cells moved in circles and in a collective way, indicating loss of directionality and a change on the migration mode that leads toward a less aggressive cell migration phenotype [<xref ref-type="bibr" rid="pone.0176226.ref008">8</xref>]. Another small RGD containing motif disintegrin, eristostatin, was reported to decrease migration speed in a wound healing assay using fibronectin coated plates and melanoma cells. Although it is not mentioned on the report, it is possible to notice impairments on cells directionality and changes on cells morphology especially on the highly invasive melanoma cell c8161 time-lapse videos [<xref ref-type="bibr" rid="pone.0176226.ref018">18</xref>]. According to Missirlis et al [<xref ref-type="bibr" rid="pone.0176226.ref039">39</xref>] the inhibition of α<sub>v</sub>β<sub>3</sub> or α<sub>5</sub>β<sub>1</sub> integrins, both on fibronectin coated surfaces caused cells to lose their directionality, but with increased migration speed [<xref ref-type="bibr" rid="pone.0176226.ref039">39</xref>]. Cilengitide was also able to disrupt cell migration, in time-lapse assays, decreasing by ~40%the migration speed in glioblastoma-derived cells, although cells were not plated over fibronectin [<xref ref-type="bibr" rid="pone.0176226.ref041">41</xref>].</p>
<p>A possible mechanism of action for the impairment of cell migration by Dis<italic>Ba</italic>-01 is the modulation of the adhesions. In order to better understand our results on the effects of Dis<italic>Ba</italic>-01 on OSCC migration, we looked deeper into cell adhesion dynamics and morphology. Fast migratory cells, such as leucocytes, are characterized by small and rapidly turning over adhesions while slow adherent migratory cell possesses persistent adhesions that mature into larger and elongated focal complexes [<xref ref-type="bibr" rid="pone.0176226.ref011">11</xref>, <xref ref-type="bibr" rid="pone.0176226.ref040">40</xref>]. Highly invasive OSCC cells have small and dynamic adhesions when plated on fibronectin, as it was already demonstrated [<xref ref-type="bibr" rid="pone.0176226.ref038">38</xref>]. Adhesion and protrusion sizes were measured and when Dis<italic>Ba</italic>-01 was added to the cells, adhesions became larger, with a higher rate of maturation and some instability could be noticed on membrane protrusions. Blocking of α5β1but not α<sub>v</sub>β<sub>3</sub> integrin by a specific ligand also increased adhesion sizes [<xref ref-type="bibr" rid="pone.0176226.ref039">39</xref>]. So adhesions function as anchors that respond to different stimuli and forces from the ECM and/or cytoskeleton altering its shape, size and dynamics according to the environment during the migration process [<xref ref-type="bibr" rid="pone.0176226.ref042">42</xref>–<xref ref-type="bibr" rid="pone.0176226.ref044">44</xref>].</p>
<p>Variations in integrin expression could lead to different migratory phenotypes and how cells are affected by Dis<italic>Ba</italic>-01. For instance, the blockage of β3 subunit by DisBa-01 did not affect the migration performance of fibroblasts probably due to the high amounts of both β1 and β3 subunits present in this cell. However, our results on the migration speed inhibition of OSCC could be due to Dis<italic>Ba</italic>-01 interaction with α<sub>v</sub>β<sub>3</sub> integrin that leaves cells with no proper traction forces to migrate, although they are still adherent, since β1 subunit is present in very limited amount. Moreover, β1 subunit has been characterized for promoting cell migration with no directionality on fibronectin coated surfaces, [<xref ref-type="bibr" rid="pone.0176226.ref045">45</xref>] such as the motile behavior seen on highly aggressive OSCC cell line in the presence of Dis<italic>Ba</italic>-01. This hypothesis was confirmed by the higher affinity that Dis<italic>Ba</italic>-01 has for α<sub>v</sub>β<sub>3</sub> integrin, as Ramos et al [<xref ref-type="bibr" rid="pone.0176226.ref026">26</xref>] first demonstrated and confirmed here, and its lower affinity for the integrin α<sub>5</sub>β<sub>1</sub>. Finally, the overexpression of β3 subunit on OSCC rescued the migratory phenotype once altered by Dis<italic>Ba</italic>-01 supporting the hypothesis that the major receptor of Dis<italic>Ba</italic>-01 is the integrin α<sub>v</sub>β<sub>3</sub>. These data show that, during invasion, epithelial-derived tumor cells switch the expression of integrins, favoring those which interact with the connective tissue, and that the specific blockage of these receptors, might impair the invasive process. On the other hand, silencing of α<sub>v</sub>β<sub>3</sub> integrin was recently demonstrated to decrease migration of both malignant glioma and triple negative breast cancer cells [<xref ref-type="bibr" rid="pone.0176226.ref046">46</xref>, <xref ref-type="bibr" rid="pone.0176226.ref047">47</xref>]. These studies are in complete agreement with our results.</p>
<p>To find new therapies for oral cancers, we showed that an RGD disintegrin changes the migration behavior of an aggressive cancer cell by decreasing its migration speed, directionality and changing adhesion phenotype upon α<sub>v</sub>β<sub>3</sub> integrin binding. This interesting phenomenon highlights cell plasticity and turning it to our own benefit could be an achievable way to fight against invasion and metastasis.</p>
</sec>
<sec id="sec015">
<title>Supporting information</title>
<supplementary-material id="pone.0176226.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0176226.s001" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Inhibition of cell invasion on matrigel in the presence of Dis<italic>Ba</italic>-01.</title>
<p>The cells were plated on the matrigel invasion inserts in the presence of Dis<italic>Ba</italic>-01 (1 μM and 2 μM) for 48 h. Invasion was expressed as a percentage of the control (100%). Cells were counted with an automated fluorescence microscope system, ImageXpress Micro (Molecular Devices). (* p&lt;0.05 compared to positive control).</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0176226.s002" mimetype="video/x-msvideo" position="float" xlink:href="info:doi/10.1371/journal.pone.0176226.s002" xlink:type="simple">
<label>S1 Movie</label>
<caption>
<title>Fibroblasts migration in presence the absence/presence of Dis<italic>Ba</italic>-01 (2μM).</title>
<p>Time-lapse images captured during 8 hours at every 10 minutes (left column) and cell tracking of migratory cells (right column). Fibroblasts were plated over fibronectin (upper line), fibronectin + DisBa-01 (2μM) added to the media (center line) and fibronectin + DisBa-01 (2μM) coated plates (bottom line).</p>
<p>(AVI)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0176226.s003" mimetype="video/x-msvideo" position="float" xlink:href="info:doi/10.1371/journal.pone.0176226.s003" xlink:type="simple">
<label>S2 Movie</label>
<caption>
<title>Highly invasive cells (OSCC) migration in presence the absence/presence of Dis<italic>Ba</italic>-01 (2μM).</title>
<p>Time-lapse images captured during 8 hours at every 10 minutes (left column) and cell tracking of migratory cells (right column). OSCC were plated over fibronectin (upper line), fibronectin + Dis<italic>Ba</italic>-01 (2μM) added to the media (center line) and fibronectin + Dis<italic>Ba</italic>-01 (2μM) coated plates (bottom line).</p>
<p>(AVI)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0176226.s004" mimetype="video/x-msvideo" position="float" xlink:href="info:doi/10.1371/journal.pone.0176226.s004" xlink:type="simple">
<label>S3 Movie</label>
<caption>
<title>Adhesion dynamics of highly invasive OSCC cells.</title>
<p>OSCC cells (SCC25) expressing the adhesion marker paxillin tagged with GFP were plated in fibronectin (left) or fibronectin + Dis<italic>Ba</italic>-01 (2μM) in the media and imaged during 20 minutes at every 3 seconds using Total Internal Reflectance Fluorescent (TIRF).</p>
<p>(AVI)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0176226.s005" mimetype="video/x-msvideo" position="float" xlink:href="info:doi/10.1371/journal.pone.0176226.s005" xlink:type="simple">
<label>S4 Movie</label>
<caption>
<title>β3 overexpressing highly invasive cells (OSCC) migration in presence the absence/presence of Dis<italic>Ba</italic>-01 (2μM).</title>
<p>Overexpressing β3OSCC subunit with images being captured during 8 hours and every 10 minutes (left column) and cell tracking (right column). Overexpressing β3OSCC migrating over fibronectin (upper line), overexpressing β3OSCC migrating over fibronectin with Dis<italic>Ba</italic>-01 (2μM) added to the media (center line) and overexpressing β3OSCC migrating over fibronectin and Dis<italic>Ba</italic>-01 (2μM) coated plates (bottom line).</p>
<p>(AVI)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0176226.s006" mimetype="video/x-msvideo" position="float" xlink:href="info:doi/10.1371/journal.pone.0176226.s006" xlink:type="simple">
<label>S5 Movie</label>
<caption>
<title>Adhesion dynamics of highly invasive OSCC cells.</title>
<p>OSCC cells (SCC25) expressing the adhesion marker paxillin tagged with mKO and β3 integrin were plated in fibronectin (left) or fibronectin + Dis<italic>Ba</italic>-01 (2μM) in the media and imaged during 20 minutes at every 3 seconds using Total Internal Reflectance Fluorescent (TIRF).</p>
<p>(AVI)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="pone.0176226.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Scully</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Bagan</surname> <given-names>J</given-names></name>. <article-title>Oral squamous cell carcinoma overview</article-title>. <source>Oral Oncol</source> <year>2009</year>;<volume>45</volume>: <fpage>301</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.oraloncology.2009.01.004" xlink:type="simple">10.1016/j.oraloncology.2009.01.004</ext-link></comment> <object-id pub-id-type="pmid">19249237</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Silva</surname> <given-names>SD Da</given-names></name>, <name name-style="western"><surname>Ferlito</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Takes</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Brakenhoff</surname> <given-names>RH</given-names></name>, <name name-style="western"><surname>Valentin</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Woolgar</surname> <given-names>JA</given-names></name>, <etal>et al</etal>. <article-title>Advances and applications of oral cancer basic research</article-title>. <source>Oral Oncol</source> <year>2011</year>; <volume>47</volume>:<fpage>783</fpage>–<lpage>91</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.oraloncology.2011.07.004" xlink:type="simple">10.1016/j.oraloncology.2011.07.004</ext-link></comment> <object-id pub-id-type="pmid">21802978</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gleber-Netto</surname> <given-names>FO</given-names></name>, <name name-style="western"><surname>Braakhuis</surname> <given-names>BJM</given-names></name>, <name name-style="western"><surname>Triantafyllou</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Takes</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Kelner</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Rodrigo</surname> <given-names>JP</given-names></name>, <etal>et al</etal>. <article-title>Molecular events in relapsed oral squamous cell carcinoma: Recurrence vs secondary primary tumor q</article-title>. <source>Oral Oncol</source> <year>2015</year>; <volume>51</volume>:<fpage>738</fpage>–<lpage>44</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.oraloncology.2015.04.016" xlink:type="simple">10.1016/j.oraloncology.2015.04.016</ext-link></comment> <object-id pub-id-type="pmid">25987307</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alizadeh</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Shiri</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Farsinejad</surname> <given-names>S</given-names></name>. <article-title>Metastasis review: from bench to bedside</article-title>. vol. <volume>35</volume>. <year>2014</year>; 35: <fpage>8483</fpage>–<lpage>523</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s13277-014-2421-z" xlink:type="simple">10.1007/s13277-014-2421-z</ext-link></comment> <object-id pub-id-type="pmid">25104089</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Friedl</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Alexander</surname> <given-names>S</given-names></name>. <article-title>Cancer invasion and the microenvironment: Plasticity and reciprocity</article-title>. <source>Cell</source> <year>2011</year>; <volume>147</volume>:<fpage>992</fpage>–<lpage>1009</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2011.11.016" xlink:type="simple">10.1016/j.cell.2011.11.016</ext-link></comment> <object-id pub-id-type="pmid">22118458</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kosmehl</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Berndt</surname> <given-names>a</given-names></name>, <name name-style="western"><surname>Strassburger</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Borsi</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Rousselle</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Mandel</surname> <given-names>U</given-names></name>, <etal>et al</etal>. <article-title>Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma</article-title>. <source>Br J Cancer</source> <year>1999</year>; <volume>81</volume>: <fpage>1071</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/sj.bjc.6690809" xlink:type="simple">10.1038/sj.bjc.6690809</ext-link></comment> <object-id pub-id-type="pmid">10576667</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Harada</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Shinohara</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Nakamura</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Oka</surname> <given-names>M</given-names></name>. <article-title>An immunohistochemical study of the extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential</article-title>. <source>Virchows Arch</source> <year>1994</year>;<volume>424</volume>:<fpage>257</fpage>–<lpage>66</lpage>. <object-id pub-id-type="pmid">7514477</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>De Oliveira Ramos</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Bernardi</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Lauxen</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Filho</surname> <given-names>MSA</given-names></name>, <name name-style="western"><surname>Horwitz</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Lamers</surname> <given-names>ML</given-names></name>. <article-title>Fibronectin modulates cell adhesion and signaling to promote single cell migration of highly invasive oral squamous cell carcinoma</article-title>. <source>PLoS One</source> <year>2016</year>; <volume>11</volume>:<fpage>1</fpage>–<lpage>18</lpage>.</mixed-citation></ref>
<ref id="pone.0176226.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vicente-Manzanares</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Horwitz</surname> <given-names>A. R.</given-names></name> <article-title>Adhesion dynamics at a glance</article-title>. <source>J Cell Sci</source> <year>2011</year>; <volume>124</volume>:<fpage>3923</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/jcs.095653" xlink:type="simple">10.1242/jcs.095653</ext-link></comment> <object-id pub-id-type="pmid">22194302</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hynes</surname> <given-names>RO</given-names></name>. <article-title>Integrins: Bidirectional, Allosteric Signaling Machines In their roles as major adhesion receptors</article-title>, <source>Cell</source> <year>2002</year>; <volume>110</volume>: <fpage>673</fpage>–<lpage>87</lpage>. <object-id pub-id-type="pmid">12297042</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Levy</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Holzbaur</surname> <given-names>ELF</given-names></name>, <name name-style="western"><surname>Parsons</surname> <given-names>JT</given-names></name>, <name name-style="western"><surname>Horwitz</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Schwartz</surname> <given-names>M a</given-names></name>, <name name-style="western"><surname>Larson</surname> <given-names>DR</given-names></name>, <etal>et al</etal>. <article-title>Cell adhesion: integrating cytoskeletal dynamics and cellular tension</article-title>. <source>Mol Cell</source> <year>2010</year>; <volume>11</volume>: <fpage>633</fpage>–<lpage>43</lpage>.</mixed-citation></ref>
<ref id="pone.0176226.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Giancotti</surname> <given-names>FG</given-names></name>, <name name-style="western"><surname>Ruoslahti</surname> <given-names>E</given-names></name>. <article-title>Integrin signaling</article-title>. <source>Science</source> <year>1999</year>; <volume>285</volume>: <fpage>1028</fpage>–<lpage>32</lpage>. <object-id pub-id-type="pmid">10446041</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Desgrosellier</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>David</surname> <given-names>C</given-names></name>. <article-title>Integrins in cancer: biological implications in therapeutic opportunities</article-title>. <source>Cancer, Nat Rev</source> <year>2015</year>; <volume>10</volume>:<fpage>9</fpage>–<lpage>22</lpage>.</mixed-citation></ref>
<ref id="pone.0176226.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schiller</surname> <given-names>HB</given-names></name>, <name name-style="western"><surname>Hermann</surname> <given-names>M-R</given-names></name>, <name name-style="western"><surname>Polleux</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Vignaud</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Zanivan</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Friedel</surname> <given-names>CC</given-names></name>, <etal>et al</etal>. <article-title>beta1- and alphav-class integrins cooperate to regulate myosin II during rigidity sensing of fibronectin-based microenvironments</article-title>. <source>Nat Cell Biol</source> <year>2013</year>; <volume>15</volume>:<fpage>625</fpage>–<lpage>36</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ncb2747" xlink:type="simple">10.1038/ncb2747</ext-link></comment> <object-id pub-id-type="pmid">23708002</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Danen</surname> <given-names>EHJ</given-names></name>, <name name-style="western"><surname>Sonneveld</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Brakebusch</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Fässler</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Sonnenberg</surname> <given-names>A</given-names></name>. <article-title>The fibronectin-binding integrins α5β1 and α<sub>v</sub>β<sub>3</sub> differentially modulate RhoA-GTP loading, organization of cell matrix adhesions, and fibronectin fibrillogenesis</article-title>. <source>J Cell Biol</source> <year>2002</year>; <volume>159</volume>:<fpage>1071</fpage>–<lpage>86</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1083/jcb.200205014" xlink:type="simple">10.1083/jcb.200205014</ext-link></comment> <object-id pub-id-type="pmid">12486108</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Morgan</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>Byron</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Humphries</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Bass</surname> <given-names>MD</given-names></name>. <article-title>Critical Review Giving off Mixed Signals—Distinct Functions of a 5 b 1 and a V b 3 Integrins in Regulating Cell Behaviour</article-title> <year>2009</year>; <volume>61</volume>: <fpage>731</fpage>–<lpage>8</lpage>.</mixed-citation></ref>
<ref id="pone.0176226.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Calvete</surname> <given-names>JJ</given-names></name>. <article-title>The continuing saga of snake venom disintegrins</article-title>. <source>Toxicon</source> <year>2013</year>; <volume>62</volume>:<fpage>40</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.toxicon.2012.09.005" xlink:type="simple">10.1016/j.toxicon.2012.09.005</ext-link></comment> <object-id pub-id-type="pmid">23010163</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tian</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Paquette-Straub</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Sage</surname> <given-names>EH</given-names></name>, <name name-style="western"><surname>Funk</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Patel</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Galileo</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Inhibition of melanoma cell motility by the snake venom disintegrin eristostatin</article-title>. <source>Toxicon</source> <year>2007</year>; <volume>49</volume>: <fpage>899</fpage>–<lpage>908</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.toxicon.2006.12.013" xlink:type="simple">10.1016/j.toxicon.2006.12.013</ext-link></comment> <object-id pub-id-type="pmid">17316731</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lucena</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Castro</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Lundin</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Hofstetter</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Alaniz</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Suntravat</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Inhibition of pancreatic tumoral cells by snake venom disintegrins</article-title>. <source>Toxicon</source> <year>2015</year>; <volume>93</volume>: <fpage>136</fpage>–<lpage>43</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.toxicon.2014.11.228" xlink:type="simple">10.1016/j.toxicon.2014.11.228</ext-link></comment> <object-id pub-id-type="pmid">25450798</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Olfa</surname> <given-names>K-Z</given-names></name>, <name name-style="western"><surname>José</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Salma</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Amine</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Najet</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Nicolas</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Lebestatin, a disintegrin from Macrovipera venom, inhibits integrin-mediated cell adhesion, migration and angiogenesis</article-title>. <source>Lab Invest</source> <year>2005</year>; <volume>85</volume>: <fpage>1507</fpage>–<lpage>16</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/labinvest.3700350" xlink:type="simple">10.1038/labinvest.3700350</ext-link></comment> <object-id pub-id-type="pmid">16200076</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Coelho</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>de Freitas</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Oliveira-Carvalho</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Moura-Neto</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Zingali</surname> <given-names>RB</given-names></name>, <name name-style="western"><surname>Barja-Fidalgo</surname> <given-names>C</given-names></name>. <article-title>Effects of jarastatin, a novel snake venom disintegrin, on neutrophil migration and actin cytoskeleton dynamics</article-title>. <source>Exp Cell Res</source> <year>1999</year>; <volume>251</volume>: <fpage>379</fpage>–<lpage>87</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1006/excr.1999.4583" xlink:type="simple">10.1006/excr.1999.4583</ext-link></comment> <object-id pub-id-type="pmid">10471323</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huang</surname> <given-names>TF</given-names></name>. <article-title>What have snakes taught us about integrins?</article-title> <source>Cell Mol Life Sci</source> <year>1998</year>; <volume>54</volume>: <fpage>527</fpage>–<lpage>40</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s000180050181" xlink:type="simple">10.1007/s000180050181</ext-link></comment> <object-id pub-id-type="pmid">9676572</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gan</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Gouldg</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Jacobs</surname> <given-names>JW</given-names></name>, <name name-style="western"><surname>Friedman</surname> <given-names>PA</given-names></name>, <name name-style="western"><surname>V</surname> <given-names>MAP</given-names></name>. <article-title>Echis carinatus</article-title>. <source>J Biol Chemol Chem</source> <year>1988</year>; <volume>263</volume>: <fpage>19827</fpage>–<lpage>32</lpage>.</mixed-citation></ref>
<ref id="pone.0176226.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Selistre-de-Araujo</surname> <given-names>HS</given-names></name>, <name name-style="western"><surname>Pontes</surname> <given-names>CLS</given-names></name>, <name name-style="western"><surname>Montenegro</surname> <given-names>CF</given-names></name>, <name name-style="western"><surname>Martin</surname> <given-names>ACBM</given-names></name>. <article-title>Snake venom disintegrins and cell migration</article-title>. <source>Toxins (Basel)</source> <year>2010</year>;<volume>2</volume>:<fpage>2606</fpage>–<lpage>21</lpage>.</mixed-citation></ref>
<ref id="pone.0176226.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cassini-Vieira</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Deconte</surname> <given-names>SR amos</given-names></name>, <name name-style="western"><surname>Tomiosso</surname> <given-names>TC arla</given-names></name>, <name name-style="western"><surname>Campos</surname> <given-names>PP eixoto</given-names></name>, <name name-style="western"><surname>Montenegro</surname> <given-names>C de F</given-names></name>, <name name-style="western"><surname>Selistre-de-Araújo</surname> <given-names>HS obreiro</given-names></name>, <etal>et al</etal>. <article-title>DisBa-01 inhibits angiogenesis, inflammation and fibrogenesis of sponge-induced-fibrovascular tissue in mice</article-title>. <source>Toxicon</source> <year>2014</year>; <volume>92</volume>:<fpage>81</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.toxicon.2014.10.007" xlink:type="simple">10.1016/j.toxicon.2014.10.007</ext-link></comment> <object-id pub-id-type="pmid">25449097</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ramos</surname> <given-names>OHP</given-names></name>, <name name-style="western"><surname>Kauskot</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Cominetti</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>Bechyne</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Salla Pontes</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>Chareyre</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>A novel α<sub>v</sub>β<sub>3</sub>-blocking disintegrin containing the RGD motive, DisBa-01, inhibits bFGF-induced angiogenesis and melanoma metastasis</article-title>. <source>Clin Exp Metastasis</source> <year>2008</year>;<volume>25</volume>:<fpage>53</fpage>–<lpage>64</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10585-007-9101-y" xlink:type="simple">10.1007/s10585-007-9101-y</ext-link></comment> <object-id pub-id-type="pmid">17952617</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Montenegro</surname> <given-names>CF</given-names></name>, <name name-style="western"><surname>Salla-Pontes</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>Ribeiro</surname> <given-names>JU</given-names></name>, <name name-style="western"><surname>MacHado</surname> <given-names>AZ</given-names></name>, <name name-style="western"><surname>Ramos</surname> <given-names>RF</given-names></name>, <name name-style="western"><surname>Figueiredo</surname> <given-names>CC</given-names></name>, <etal>et al</etal>. <article-title>Blocking αvβ3 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells</article-title>. <source>Biochimie</source> <year>2012</year>; <volume>94</volume>: <fpage>1812</fpage>–<lpage>20</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.biochi.2012.04.020" xlink:type="simple">10.1016/j.biochi.2012.04.020</ext-link></comment> <object-id pub-id-type="pmid">22561350</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Colley</surname> <given-names>HE</given-names></name>, <name name-style="western"><surname>Hearnden</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Jones a</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Weinreb</surname> <given-names>PH</given-names></name>, <name name-style="western"><surname>Violette</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Macneil</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Development of tissue-engineered models of oral dysplasia and early invasive oral squamous cell carcinoma</article-title>. <source>Br J Cancer</source> <year>2011</year>; <volume>105</volume>: <fpage>1582</fpage>–<lpage>92</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/bjc.2011.403" xlink:type="simple">10.1038/bjc.2011.403</ext-link></comment> <object-id pub-id-type="pmid">21989184</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Laukaitis</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Webb</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Donais</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Horwitz</surname> <given-names>AF</given-names></name>. <article-title>Differential dynamics of α5 integrin, paxillin, and α-actinin during formation and disassembly of adhesions in migrating cells</article-title>. <source>J Cell Biol</source> <year>2001</year>; <volume>153</volume>:<fpage>1427</fpage>–<lpage>40</lpage>. <object-id pub-id-type="pmid">11425873</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lamers</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Almeida</surname> <given-names>MES</given-names></name>, <name name-style="western"><surname>Vicente-Manzanares</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Horwitz</surname> <given-names>AF</given-names></name>, <name name-style="western"><surname>Santos</surname> <given-names>MF</given-names></name>. <article-title>High glucose-mediated oxidative stress impairs cell migration</article-title>. <source>PLoS One</source> <year>2011</year>;<volume>6</volume>:<fpage>1</fpage>–<lpage>9</lpage>.</mixed-citation></ref>
<ref id="pone.0176226.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Choi</surname> <given-names>CK</given-names></name>, <name name-style="western"><surname>Vicente-Manzanares</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Zareno</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Whitmore</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Mogilner</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Horwitz</surname> <given-names>AR</given-names></name>. <article-title>Actin and α-actinin orchestrate the assembly and maturation of nascent adhesions in a myosin II motor-independent manner</article-title>. <source>Nat Cell Biol</source> <year>2008</year>; <volume>10</volume>:<fpage>1039</fpage>–<lpage>50</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ncb1763" xlink:type="simple">10.1038/ncb1763</ext-link></comment> <object-id pub-id-type="pmid">19160484</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leavesley</surname> <given-names>G.D.</given-names></name>; <name name-style="western"><surname>Wayner</surname> <given-names>E.A.</given-names></name>; <name name-style="western"><surname>Cheresh</surname> <given-names>D.A. DI. F</given-names></name>. <article-title>Requirement of the Integrin β3 subunit for carcinoma cell spreading or migration on vitronectin and fibronectin</article-title>. <source>J Cell Biol</source> <year>1992</year>; <volume>117</volume>: <fpage>1101</fpage>–<lpage>7</lpage>. <object-id pub-id-type="pmid">1374415</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bissell</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Hines</surname> <given-names>WC</given-names></name>. <article-title>Why don’t we get more cancer? A proposed role of the microenvironment in restraining cancer progression</article-title>. <source>Nat Med</source> <year>2011</year>; <volume>17</volume>: <fpage>320</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nm.2328" xlink:type="simple">10.1038/nm.2328</ext-link></comment> <object-id pub-id-type="pmid">21383745</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Friedl</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Wolf</surname> <given-names>K</given-names></name>. <article-title>Plasticity of cell migration: a multiscale tuning model</article-title>. <source>J Cell Biol</source> <year>2010</year>; <volume>188</volume>: <fpage>11</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1083/jcb.200909003" xlink:type="simple">10.1083/jcb.200909003</ext-link></comment> <object-id pub-id-type="pmid">19951899</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stupp</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Hegi</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Gorlia</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Erridge</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Perry</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Hong</surname> <given-names>Y-K</given-names></name>, <etal>et al</etal>. <article-title>Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071–22072 study): a multicentre, randomised, open-label, phase 3 trial</article-title>. <source>Lancet Oncol</source> <year>2014</year>; <volume>15</volume>: <fpage>1100</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S1470-2045(14)70379-1" xlink:type="simple">10.1016/S1470-2045(14)70379-1</ext-link></comment> <object-id pub-id-type="pmid">25163906</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reardon</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Cheresh</surname> <given-names>D</given-names></name>. <article-title>Cilengitide: a prototypic integrin inhibitor for the treatment of glioblastoma and other malignancies</article-title>. <source>Genes Cancer</source> <year>2011</year>; <volume>2</volume>: <fpage>1159</fpage>–<lpage>65</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/1947601912450586" xlink:type="simple">10.1177/1947601912450586</ext-link></comment> <object-id pub-id-type="pmid">22866207</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Marcinkiewicz</surname> <given-names>C</given-names></name>. <article-title>Applications of snake venom components to modulate integrin activities in cell–matrix interactions</article-title>. <source>Int J Biochem Cell Biol</source> <year>2013</year>; <volume>45</volume>: <fpage>1974</fpage>–<lpage>86</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.biocel.2013.06.009" xlink:type="simple">10.1016/j.biocel.2013.06.009</ext-link></comment> <object-id pub-id-type="pmid">23811033</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Friedl</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Wolf</surname> <given-names>K</given-names></name>. <article-title>Tumour-cell invasion and migration: diversity and escape mechanisms</article-title>. <source>Nat Rev Cancer</source> <year>2003</year>; <volume>3</volume>: <fpage>362</fpage>–<lpage>74</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrc1075" xlink:type="simple">10.1038/nrc1075</ext-link></comment> <object-id pub-id-type="pmid">12724734</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Missirlis</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Haraszti</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Scheele</surname> <given-names>C v C</given-names></name>, <name name-style="western"><surname>Wiegand</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Diaz</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Neubauer</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Substrate engagement of integrins α5β1 and α<sub>v</sub>β<sub>3</sub> is necessary, but not sufficient, for high directional persistence in migration on fibronectin</article-title>. <source>Sci Rep</source> <year>2016</year>; <volume>6</volume>: <fpage>23258</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/srep23258" xlink:type="simple">10.1038/srep23258</ext-link></comment> <object-id pub-id-type="pmid">26987342</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Vicente-Manzanares</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Potvin-Trottier</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Wiseman</surname> <given-names>PW</given-names></name>, <name name-style="western"><surname>Horwitz</surname> <given-names>AR</given-names></name>. <article-title>The integrin-ligand interaction regulates adhesion and migration through a molecular clutch</article-title>. <source>PLoS One</source> <year>2012</year>; <volume>7</volume>: <fpage>e40202</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0040202" xlink:type="simple">10.1371/journal.pone.0040202</ext-link></comment> <object-id pub-id-type="pmid">22792239</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Anderson</surname> <given-names>HJ</given-names></name>, <name name-style="western"><surname>Galileo</surname> <given-names>DS</given-names></name>. <article-title>Small-molecule inhibitors of FGFR, integrins and FAK selectively decrease L1CAM-stimulated glioblastoma cell motility and proliferation</article-title>. <source>Cell Oncol</source> <year>2016</year>; <volume>39</volume>: <fpage>229</fpage>–<lpage>42</lpage>.</mixed-citation></ref>
<ref id="pone.0176226.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Oakes</surname> <given-names>PW</given-names></name>, <name name-style="western"><surname>Gardel</surname> <given-names>ML</given-names></name>. <article-title>Stressing the limits of focal adhesion mechanosensitivity</article-title>. <source>Curr Opin Cell Biol</source> <year>2014</year>; <volume>30</volume>: <fpage>68</fpage>–<lpage>73</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ceb.2014.06.003" xlink:type="simple">10.1016/j.ceb.2014.06.003</ext-link></comment> <object-id pub-id-type="pmid">24998185</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barnhart</surname> <given-names>EL</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>KC</given-names></name>, <name name-style="western"><surname>Keren</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Mogilner</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Theriot</surname> <given-names>JA</given-names></name>. <article-title>An adhesion-dependent switch between mechanisms that determine motile cell shape</article-title>. <source>PLoS Biol</source> <year>2011</year>; <volume>9</volume>: <fpage>e1001059</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pbio.1001059" xlink:type="simple">10.1371/journal.pbio.1001059</ext-link></comment> <object-id pub-id-type="pmid">21559321</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Di Cio</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Gautrot</surname> <given-names>JE</given-names></name>. <article-title>Cell sensing of physical properties at the nanoscale: Mechanisms and control of cell adhesion and phenotype</article-title>. <source>Acta Biomater</source> <year>2016</year>; <volume>30</volume>:<fpage>26</fpage>–<lpage>48</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.actbio.2015.11.027" xlink:type="simple">10.1016/j.actbio.2015.11.027</ext-link></comment> <object-id pub-id-type="pmid">26596568</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Danen</surname> <given-names>EHJ</given-names></name>, <name name-style="western"><surname>Van Rheenen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Franken</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Huveneers</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Sonneveld</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Jalink</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Integrins control motile strategy through a Rho-cofilin pathway</article-title>. <source>J Cell Biol</source> <year>2005</year>; <volume>169</volume>: <fpage>515</fpage>–<lpage>26</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1083/jcb.200412081" xlink:type="simple">10.1083/jcb.200412081</ext-link></comment> <object-id pub-id-type="pmid">15866889</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Parvani</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Gujrati</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Mack</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Schiemann</surname> <given-names>WP</given-names></name>, <name name-style="western"><surname>Lu</surname> <given-names>ZR</given-names></name>. <article-title>Silencing β3 integrin by targeted ECO/siRNA nanoparticles inhibits EMT and metastasis of triple-negative breast cancer</article-title>. <source>Cancer Res</source> <year>2015</year>; <volume>75</volume>(<issue>11</issue>): <fpage>2316</fpage>–<lpage>25</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/0008-5472.CAN-14-3485" xlink:type="simple">10.1158/0008-5472.CAN-14-3485</ext-link></comment> <object-id pub-id-type="pmid">25858145</object-id></mixed-citation></ref>
<ref id="pone.0176226.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Christmann</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Diesler</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Majhen</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Steigerwald</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Berte</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Freund</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Integrin α<sub>v</sub>β<sub>3</sub> silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair</article-title>. <source>Oncotarget</source> <year>2016</year>; [Epub ahead of print].</mixed-citation></ref>
</ref-list>
</back>
</article>